These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 34783061)
1. Construction of an m6A-related lncRNA pair prognostic signature and prediction of the immune landscape in head and neck squamous cell carcinoma. Zhou C; Wang S; Shen Z; Shen Y; Li Q; Shen Y; Huang J; Deng H; Ye D; Zhan G; Li J J Clin Lab Anal; 2022 Jan; 36(1):e24113. PubMed ID: 34783061 [TBL] [Abstract][Full Text] [Related]
2. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma. Zhu W; Ye Z; Chen L; Liang H; Cai Q Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154 [TBL] [Abstract][Full Text] [Related]
3. A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma. Chen L; Cai Z; Lyu K; Cai Z; Lei W Bioengineered; 2021 Dec; 12(1):2311-2325. PubMed ID: 34167440 [TBL] [Abstract][Full Text] [Related]
4. A Signature of N Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X Front Immunol; 2022; 13():809872. PubMed ID: 35185897 [TBL] [Abstract][Full Text] [Related]
5. Identification of immune-related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma. Li Q; Shen Z; Shen Y; Deng H; Shen Y; Wang J; Zhan G; Zhou C J Clin Lab Anal; 2022 Jun; 36(6):e24484. PubMed ID: 35561269 [TBL] [Abstract][Full Text] [Related]
6. Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma. Huang J; Xu Z; Teh BM; Zhou C; Yuan Z; Shi Y; Shen Y J Clin Lab Anal; 2022 Jun; 36(6):e24480. PubMed ID: 35522142 [TBL] [Abstract][Full Text] [Related]
7. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma. Mao R; Chen Y; Xiong L; Liu Y; Zhang T Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878 [TBL] [Abstract][Full Text] [Related]
8. A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma. Zhou C; Shen Y; Jin Y; Shen Z; Ye D; Shen Y; Deng H Cancer Med; 2022 Dec; 11(24):5097-5112. PubMed ID: 35567376 [TBL] [Abstract][Full Text] [Related]
9. The prognostic value of m6A-related LncRNAs in patients with HNSCC: bioinformatics analysis of TCGA database. Zhou LQ; Shen JX; Zhou JY; Hu Y; Xiao HJ Sci Rep; 2022 Jan; 12(1):579. PubMed ID: 35022464 [TBL] [Abstract][Full Text] [Related]
10. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer. Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791 [No Abstract] [Full Text] [Related]
11. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma. Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580 [TBL] [Abstract][Full Text] [Related]
12. An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma. Qian L; Ni T; Fei B; Sun H; Ni H BMC Cancer; 2022 May; 22(1):545. PubMed ID: 35568824 [TBL] [Abstract][Full Text] [Related]
13. Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma. Wang J; Bian Q; Liu J; Moming A Bioengineered; 2021 Dec; 12(2):10049-10062. PubMed ID: 34872450 [TBL] [Abstract][Full Text] [Related]
14. Identification of several senescence-associated genes signature in head and neck squamous cell carcinoma. Wang J; Zhou CC; Sun HC; Li Q; Hu JD; Jiang T; Zhou S J Clin Lab Anal; 2022 Jul; 36(7):e24555. PubMed ID: 35692082 [TBL] [Abstract][Full Text] [Related]
15. A N6-methyladenosine-related long noncoding RNAs model for predicting prognosis in oral squamous cell carcinoma: Association with immune cell infiltration and tumor metastasis. Yang Q; Cheng C; Zhu R; Guo F; Lai R; Liu X; Li M Oral Oncol; 2022 Apr; 127():105771. PubMed ID: 35189585 [TBL] [Abstract][Full Text] [Related]
16. Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas. Ma B; Li H; Qiao J; Meng T; Yu R Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33111959 [TBL] [Abstract][Full Text] [Related]
17. An immune-related seven-lncRNA signature for head and neck squamous cell carcinoma. Chen Y; Luo TQ; Xu SS; Chen CY; Sun Y; Lin L; Mao YP Cancer Med; 2021 Apr; 10(7):2268-2285. PubMed ID: 33660378 [TBL] [Abstract][Full Text] [Related]
18. Development of a lncRNA-based prognostic signature for oral squamous cell carcinoma. Xu Z; Li X; Pan L; Tan R; Ji P; Tang H J Oral Pathol Med; 2022 Apr; 51(4):358-368. PubMed ID: 35100473 [TBL] [Abstract][Full Text] [Related]
19. Prognostic prediction of head and neck squamous cell carcinoma: Construction of cuproptosis-related long non-coding RNA signature. Huang Q; You Q; Zhu N; Wu Z; Xiang Z; Wu K; Ren J; Gui Y J Clin Lab Anal; 2022 Nov; 36(11):e24723. PubMed ID: 36189780 [TBL] [Abstract][Full Text] [Related]
20. Establishment and validation of a redox-related long non-coding RNAs prognostic signature in head and neck squamous cell carcinoma. Liu K; Huang T; Zhang H; Deng H; Tang M Sci Rep; 2022 Dec; 12(1):22040. PubMed ID: 36543836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]